383 related articles for article (PubMed ID: 17313817)
21. Quantification of platelet function - a comparative study of venous and arterial blood using a novel flow cytometry protocol.
Törnudd M; Rodwan Al Ghraoui M; Wahlgren S; Björkman E; Berg S; Kvitting JP; Alfredsson J; Ramström S
Platelets; 2022 Aug; 33(6):926-934. PubMed ID: 35073813
[TBL] [Abstract][Full Text] [Related]
22. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
Wu CC; Wu SY; Liao CY; Teng CM; Wu YC; Kuo SC
Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
[TBL] [Abstract][Full Text] [Related]
23. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
[TBL] [Abstract][Full Text] [Related]
24. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
[TBL] [Abstract][Full Text] [Related]
25. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
Chaudhary PK; Kim S
J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
[TBL] [Abstract][Full Text] [Related]
27. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization.
Mazharian A; Roger S; Berrou E; Adam F; Kauskot A; Nurden P; Jandrot-Perrus M; Bryckaert M
J Biol Chem; 2007 Feb; 282(8):5478-87. PubMed ID: 17200114
[TBL] [Abstract][Full Text] [Related]
28. Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP.
Adam F; Verbeuren TJ; Fauchère JL; Guillin MC; Jandrot-Perrus M
J Thromb Haemost; 2003 Apr; 1(4):798-804. PubMed ID: 12871418
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
30. Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.
Holinstat M; Colowick NE; Hudson WJ; Blakemore D; Chen Q; Hamm HE; Cleator JH
J Thromb Thrombolysis; 2013 Feb; 35(2):209-22. PubMed ID: 23054462
[TBL] [Abstract][Full Text] [Related]
31. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.
Lova P; Campus F; Lombardi R; Cattaneo M; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2004 Jun; 279(24):25299-306. PubMed ID: 15078882
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.
Fälker K; Haglund L; Gunnarsson P; Nylander M; Lindahl TL; Grenegård M
Biochem J; 2011 Jun; 436(2):469-80. PubMed ID: 21391917
[TBL] [Abstract][Full Text] [Related]
33. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.
Carrim N; Arthur JF; Hamilton JR; Gardiner EE; Andrews RK; Moran N; Berndt MC; Metharom P
Redox Biol; 2015 Dec; 6():640-647. PubMed ID: 26569550
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
[TBL] [Abstract][Full Text] [Related]
35. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
[TBL] [Abstract][Full Text] [Related]
36. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase.
Trumel C; Payrastre B; Plantavid M; Hechler B; Viala C; Presek P; Martinson EA; Cazenave JP; Chap H; Gachet C
Blood; 1999 Dec; 94(12):4156-65. PubMed ID: 10590060
[TBL] [Abstract][Full Text] [Related]
37. C1-inhibitor influence on platelet activation by thrombin receptors agonists.
Tarandovskiy ID; Buehler PW; Karnaukhova E
Clin Appl Thromb Hemost; 2022; 28():10760296221120422. PubMed ID: 35996317
[TBL] [Abstract][Full Text] [Related]
38. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
[TBL] [Abstract][Full Text] [Related]
39. Adenylate cyclase inhibition is required for normal redistribution of platelet surface GPIb in response to PAR1 activation.
Pouget T; Pillois X; Fiore M
Thromb Res; 2019 Jan; 173():151-154. PubMed ID: 30530120
[No Abstract] [Full Text] [Related]
40. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
